MRA(Tocilizumab)

DRUG11 trials

Sponsors

Chugai Pharmaceutical

Conditions

Polyarticular Juvenile Idiopathic ArthritisRheumatoid ArthritisSystemic Juvenile Idiopathic Arthritis

Phase 2

Study of MRA in Patients With Rheumatoid Arthritis (RA)

CompletedNCT00144651

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2001-08-31End: 2009-06-30Updated: 2013-08-09

Phase 3

Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

CompletedNCT00144599

Chugai PharmaceuticalSystemic Juvenile Idiopathic Arthritis

Start: 2004-05-31End: 2005-10-31Updated: 2008-07-30

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP

CompletedNCT00144547

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2004-04-30End: 2009-06-30Updated: 2013-08-09

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

CompletedNCT00144625

Chugai PharmaceuticalPolyarticular Juvenile Idiopathic Arthritis

Start: 2005-02-28End: 2009-06-30Updated: 2009-12-23

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

CompletedNCT00144612

Chugai PharmaceuticalSystemic Juvenile Idiopathic Arthritis

Start: 2004-07-31End: 2009-06-30Updated: 2009-12-23

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

CompletedNCT00144521

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2004-02-29End: 2006-04-30Updated: 2009-02-02

Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JP

CompletedNCT00144586

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2005-03-31End: 2009-06-30Updated: 2013-08-09

Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

CompletedNCT00144664

Chugai PharmaceuticalSystemic Juvenile Idiopathic Arthritis

Start: 2004-11-30End: 2005-10-31Updated: 2008-07-30

PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)

CompletedNCT00380601

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2006-05-31End: 2009-02-28Target: 20Updated: 2009-12-23

Unknown Phase

Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment

CompletedNCT00144573

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2005-01-31End: 2005-10-31Updated: 2008-12-15

Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)

CompletedNCT00144560

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2005-02-28End: 2005-08-31Updated: 2008-12-15

Related Papers

Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.

2014-05-0120 citations

Longterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan

The Journal of Rheumatology2014-03-1570 citations

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

2008-03-01522 citations